Concepedia

Publication | Closed Access

The Prognostic Value of Plasma YKL-40 in Patients With Chemotherapy-Resistant Ovarian Cancer Treated With Bevacizumab

21

Citations

30

References

2016

Year

References

YearCitations

Page 1